ecancermedicalscience

Short Communication

Cancer care during the COVID-19 pandemic: a perspective from Saudi Arabia

17 Jul 2020
Saleh A Alessy, Elizabeth A Davies, Abdul-Rahman Jazieh

The coronavirus disease 2019 (COVID-19) pandemic continues to disrupt many healthcare settings worldwide including cancer care. COVID-19 has been associated with worse outcomes amongst cancer patients. Saudi Arabia has experienced several Middle East respiratory syndrome coronavirus (MERS-CoV) outbreaks that affected the continuity of cancer care. In this paper, we describe how Saudi Arabia responded to COVID-19, how cancer care was re-restructured during this pandemic and how the recent MERS-CoV experience may have improved the Saudi response to COVID-19.

Related Articles

Monika Sarade, Dipak Das, Sharyu Mhamane, Sandip Bhojane, Suvarna Patil, Shripad Banavali, Gagan Prakash, Atul Budukh
Juan Carlos Nuñez-Enriquez Daniela Medina-León, Diana Tinoco-Montejano, Karen Jacuinde-Trejo, Janet Flores-Lujano, Lissette Gómez-Rivera, Omar Chávez-Martínez, Francisco J García-Alvarado, Patricia Blanco-Padilla, Rosana Pelayo
Israel Fernandez-Pineda, Simone de Campos Vieira Abib, Tristan Boam, Diego Aspiazu Salinas, Samer Michael, Justin Ted Gerstle, Steven Warmann, Jorg Fuchs, Alyssa Stetson, Gloria Gonzalez, Greg Tiao, Timothy B. Lautz, Rodrigo Chaves Ribeiro, Roshni Dasgupta, Jaime Shalkow-Klincovstein, Cristian Puerta, Andrew M. Davidoff, Marianna Cornet, Julien Grosman, Aurore Pire, Sabine Sarnacki, Thomas Blanc, Abdelhafeez H Abdelhafeez